LERCANIDIPINE

作品数：5被引量：5H指数：2
导出分析报告
相关领域：医药卫生更多>>
相关机构：台湾大学更多>>
相关期刊：《Journal of Pharmaceutical Analysis》《Acta Pharmacologica Sinica》《Chinese Medical Journal》《World Journal of Cardiology》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-5
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Determination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study被引量：2
《Journal of Pharmaceutical Analysis》2016年第2期87-94,共8页Darshan V.Chaudhary Daxesh P.Patel Priyanka A.Shah Jaivik V.Shah Mallika Sanyal Pranav S.Shrivastav 
UGC-BSR (F 4-1/2009 (BSR)/7-74/2007);New Delhi, for research fellowship, F 4-1/2009 (BSR)/7-74/2007;Department of Chemistry, Gujarat University, for supporting this work
An improved and reliable ultra-performance liquid chromatography/tandem mass spectrometry （UPLC- MS/MS） method has been developed and validated for the determination of lercanidipine in human plasma. Plasma samples ...
关键词：LERCANIDIPINE UPLC-MS/MS BIOEQUIVALENCE Solid phase extraction Human plasma 
Thrapeutic equivalence in the treatment of hypertension:Can lercanidipine and nifedipine GITS be considered to be interchangeable?被引量：1
《World Journal of Cardiology》2014年第6期507-513,共7页Henry L Elliott Peter A Meredith 
AIM: To undertake a review of the evidence that nifedipine GITS and lercanidipine are therapeutically equivalent in the management of essential hypertension.METHODS: A systematic review of the published literature was...
关键词：Nifedipine GITS LERCANIDIPINE Therapeutic equivalence 
Efficacy and safety of the treatment： combination of benazepril/ lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension被引量：2
《Chinese Medical Journal》2013年第12期2286-2290,共5页CHEN Ting CHEN Guang-hui YANG Ting-shu ZHONG Zhen-yu AN Wei-shuai ZHANG Xiao-xia LI Jia-dan 
Background Combination therapy is an effective method to reduce the blood pressure （BP） for patients with hypertension.This study was performed to evaluate the efficacy and safety of benazepril/lercanidipine compare...
关键词：HYPERTENSION combination therapy BENAZEPRIL LERCANIDIPINE 
Lercanidipine及其他钙离子阻断剂在高血压方面的使用
《中国医药技术与市场》2007年第2期62-64,共3页
1882年Dr．Ringer发现肌肉收缩与体外钙离子浓度有关开始，科学家便想如果可以减少钙进入细胞，就应该能减少肌肉收缩。1962年Dr．AlbrechtFleckenstdn研究发展出第一个钙离子阻断剂-Verapamil，此后，陆陆继继有许多的华学分子被筛选...
关键词：钙离子阻断剂 高血压 NIFEDIPINE verapamil DILTIAZEM FELODIPINE NIMODIPINE AMLODIPINE 
Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters
《Acta Pharmacologica Sinica》2003年第3期199-206,共8页MassicotteJ. LeonardiA. 等 
AIM: Lercanidipine is a new vasoselective dihydropyridine calcium channel blocker with a short plasma half-life, long duration of action, and demonstrated cardioprotective properties. We hypothesized that it might be ...
关键词：Acetylcholine Animals Calcium Channel Blockers Capillaries Cardiomyopathies Cardiotonic Agents CRICETINAE DIHYDROPYRIDINES Female Heart Failure  Congestive Male MESOCRICETUS Myocardium NITROPRUSSIDE Research Support  Non-U.S. Gov't Vasodilator Agents Ventricular Remodeling 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部